- Real-world evidence has become central to payer conversations. And it’s regularly the least-read part of the submission, not because it’s weak.
- The real-world data a team already has is usually good enough to make the case on its own. What it needs is a shape a busy reader can follow.
- We take the real-world evidence that's already approved and turn it into a visual story. Zero new claims, every element mapped to the source data.
Strong real-world evidence often gets missed simply because it’s hard to find. Here's what we found, and what it means for how you build your next story.
01Good evidence, buried well
Real-world evidence has become central to payer conversations. And it’s regularly the least-read part of the submission, not because it’s weak, because it arrives as another dense document.
of the time, physicians read only the abstract of a publication, not the full paper.
MLR review covers every version, however many journeys one approved core holds.
languages one approved core is produced in, without restarting the scientific review each time.
Every figure here is independently sourced.
02The data isn’t the problem
The real-world data a team already has is usually good enough to make the case on its own. What it needs is a format that gets a payer to the result fast, without making her hunt through methodology sections.
“What it needs is a format that gets a payer to the result fast, without making her hunt through methodology sections.”
03What visualization actually changes
We take the real-world evidence that's already approved and turn it into a visual story. Zero new claims created, every element maps to the source data exactly as filed.
04Depth without five different decks
A pharmacy director wants the budget impact angle. A medical director wants the comparative outcomes. One approved evidence base can let each reader go to the depth their role requires, still covered by a single MLR review.